Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)

Albrecht Reichle; Daniel Heudobler; Christopher Gerner; Pan Pantziarka; Eugenio Martinelli; Ernst Holler; Francesca Corsi; Lina Ghibelli

doi:10.3389/fonc.2020.01675

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)

Front Oncol. 2020 Sep 2:10:1675. doi: 10.3389/fonc.2020.01675. eCollection 2020.

Authors

Albrecht Reichle¹, Daniel Heudobler¹, Christopher Gerner², Pan Pantziarka^{3

4}, Eugenio Martinelli⁵, Ernst Holler¹, Francesca Corsi^{6

7}, Lina Ghibelli⁶

Affiliations

¹ Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
² Faculty Chemistry, Institut for Analytical Chemistry, University Vienna, Vienna, Austria.
³ The George Pantziarka TP53 Trust, London, United Kingdom.
⁴ Anticancer Fund, Brussels, Belgium.
⁵ Department of Electronic Engineering, University of Rome Tor Vergata, Rome, Italy.
⁶ Department Biology, Universita' di Roma Tor Vergata, Rome, Italy.
⁷ Department of Chemical Sciences and Technologies, Universita' di Roma Tor Vergata, Rome, Italy.

No abstract available

Keywords: anakoinosis; biomodulatory drugs; chemoprevention; master modifiers of tumor tissues; refractory metastatic cancer; reverse anakoinosis; targeted tissue engineering; tissue homeostasis.

Publication types

Editorial